S&P 500   4,567.60 (+0.28%)
DOW   35,544.55 (+0.36%)
QQQ   391.32 (+0.29%)
AAPL   189.83 (-0.30%)
MSFT   378.51 (-1.09%)
META   333.77 (-1.54%)
GOOGL   135.75 (-1.06%)
AMZN   146.39 (-0.44%)
TSLA   248.89 (+0.88%)
NVDA   482.22 (+0.84%)
NIO   7.24 (+0.42%)
BABA   74.77 (-2.57%)
AMD   124.65 (+2.16%)
T   16.24 (+0.37%)
F   10.66 (+2.80%)
MU   77.36 (+1.63%)
CGC   0.55 (+1.78%)
GE   119.43 (+0.49%)
DIS   92.78 (+0.30%)
AMC   7.06 (+5.37%)
PFE   30.04 (+1.18%)
PYPL   58.58 (+0.19%)
XOM   103.25 (-0.63%)
S&P 500   4,567.60 (+0.28%)
DOW   35,544.55 (+0.36%)
QQQ   391.32 (+0.29%)
AAPL   189.83 (-0.30%)
MSFT   378.51 (-1.09%)
META   333.77 (-1.54%)
GOOGL   135.75 (-1.06%)
AMZN   146.39 (-0.44%)
TSLA   248.89 (+0.88%)
NVDA   482.22 (+0.84%)
NIO   7.24 (+0.42%)
BABA   74.77 (-2.57%)
AMD   124.65 (+2.16%)
T   16.24 (+0.37%)
F   10.66 (+2.80%)
MU   77.36 (+1.63%)
CGC   0.55 (+1.78%)
GE   119.43 (+0.49%)
DIS   92.78 (+0.30%)
AMC   7.06 (+5.37%)
PFE   30.04 (+1.18%)
PYPL   58.58 (+0.19%)
XOM   103.25 (-0.63%)
S&P 500   4,567.60 (+0.28%)
DOW   35,544.55 (+0.36%)
QQQ   391.32 (+0.29%)
AAPL   189.83 (-0.30%)
MSFT   378.51 (-1.09%)
META   333.77 (-1.54%)
GOOGL   135.75 (-1.06%)
AMZN   146.39 (-0.44%)
TSLA   248.89 (+0.88%)
NVDA   482.22 (+0.84%)
NIO   7.24 (+0.42%)
BABA   74.77 (-2.57%)
AMD   124.65 (+2.16%)
T   16.24 (+0.37%)
F   10.66 (+2.80%)
MU   77.36 (+1.63%)
CGC   0.55 (+1.78%)
GE   119.43 (+0.49%)
DIS   92.78 (+0.30%)
AMC   7.06 (+5.37%)
PFE   30.04 (+1.18%)
PYPL   58.58 (+0.19%)
XOM   103.25 (-0.63%)
S&P 500   4,567.60 (+0.28%)
DOW   35,544.55 (+0.36%)
QQQ   391.32 (+0.29%)
AAPL   189.83 (-0.30%)
MSFT   378.51 (-1.09%)
META   333.77 (-1.54%)
GOOGL   135.75 (-1.06%)
AMZN   146.39 (-0.44%)
TSLA   248.89 (+0.88%)
NVDA   482.22 (+0.84%)
NIO   7.24 (+0.42%)
BABA   74.77 (-2.57%)
AMD   124.65 (+2.16%)
T   16.24 (+0.37%)
F   10.66 (+2.80%)
MU   77.36 (+1.63%)
CGC   0.55 (+1.78%)
GE   119.43 (+0.49%)
DIS   92.78 (+0.30%)
AMC   7.06 (+5.37%)
PFE   30.04 (+1.18%)
PYPL   58.58 (+0.19%)
XOM   103.25 (-0.63%)

Ryan Specialty Stock Price, News & Analysis (NYSE:RYAN)

$45.43
+0.03 (+0.07%)
(As of 12:33 PM ET)
Compare
Today's Range
$45.23
$45.57
50-Day Range
$43.15
$49.33
52-Week Range
$35.10
$50.64
Volume
127,519 shs
Average Volume
661,635 shs
Market Capitalization
$11.82 billion
P/E Ratio
96.66
Dividend Yield
N/A
Price Target
$51.14

Ryan Specialty MarketRank™ Stock Analysis

Analyst Rating
Hold
2.43 Rating Score
Upside/​Downside
12.4% Upside
$51.14 Price Target
Short Interest
Bearish
6.05% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$471,656 Sold Last Quarter
Proj. Earnings Growth
23.19%
From $1.38 to $1.70 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.23 out of 5 stars

Finance Sector

465th out of 860 stocks

Insurance Agents, Brokers, & Service Industry

11th out of 16 stocks


RYAN stock logo

About Ryan Specialty Stock (NYSE:RYAN)

Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter. The company serves commercial, industrial, institutional, and government sectors. Ryan Specialty Holdings, Inc. was founded in 2010 and is headquartered in Chicago, Illinois.

RYAN Stock Price History

RYAN Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
What 4 Analyst Ratings Have To Say About Ryan Specialty Hldgs
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
Ryan Specialty Group (RYAN) Meets Q3 Earnings Estimates
Ryan Specialty Reports Third Quarter 2023 Results
Ryan T. Johnson
Ryan Specialty to Acquire AccuRisk Holdings
AccuRisk Holdings to be Acquired by Ryan Specialty
See More Headlines
Receive RYAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ryan Specialty and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/02/2023
Today
11/29/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/27/2024

Industry, Sector and Symbol

Industry
Insurance agents, brokers, & service
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
3,850
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$51.14
High Stock Price Target
$59.00
Low Stock Price Target
$43.00
Potential Upside/Downside
+12.5%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

Net Income
$61.05 million
Pretax Margin
11.64%

Debt

Sales & Book Value

Annual Sales
$1.73 billion
Cash Flow
$1.66 per share
Book Value
$3.62 per share

Miscellaneous

Free Float
118,388,000
Market Cap
$11.83 billion
Optionable
Not Optionable
Beta
0.46
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives















RYAN Stock Analysis - Frequently Asked Questions

Should I buy or sell Ryan Specialty stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ryan Specialty in the last twelve months. There are currently 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" RYAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RYAN, but not buy additional shares or sell existing shares.
View RYAN analyst ratings
or view top-rated stocks.

What is Ryan Specialty's stock price target for 2024?

7 equities research analysts have issued twelve-month target prices for Ryan Specialty's shares. Their RYAN share price targets range from $43.00 to $59.00. On average, they predict the company's stock price to reach $51.14 in the next twelve months. This suggests a possible upside of 12.4% from the stock's current price.
View analysts price targets for RYAN
or view top-rated stocks among Wall Street analysts.

How have RYAN shares performed in 2023?

Ryan Specialty's stock was trading at $41.51 at the start of the year. Since then, RYAN stock has increased by 9.6% and is now trading at $45.49.
View the best growth stocks for 2023 here
.

When is Ryan Specialty's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our RYAN earnings forecast
.

How were Ryan Specialty's earnings last quarter?

Ryan Specialty Holdings, Inc. (NYSE:RYAN) announced its quarterly earnings results on Thursday, November, 2nd. The company reported $0.32 earnings per share for the quarter, hitting the consensus estimate of $0.32. The business had revenue of $501.94 million for the quarter, compared to the consensus estimate of $500.92 million. Ryan Specialty had a net margin of 9.18% and a trailing twelve-month return on equity of 42.39%.

What ETFs hold Ryan Specialty's stock?
When did Ryan Specialty IPO?

(RYAN) raised $1.3 billion in an IPO on Thursday, July 22nd 2021. The company issued 56,918,278 shares at $22.00-$25.00 per share.

Who are Ryan Specialty's major shareholders?

Ryan Specialty's stock is owned by a variety of institutional and retail investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (3.92%), Artisan Partners Limited Partnership (1.09%), Blair William & Co. IL (1.02%), Morgan Stanley (0.81%), Victory Capital Management Inc. (0.69%) and Ameriprise Financial Inc. (0.57%). Insiders that own company stock include Brendan Martin Mulshine, Corp Onex, David P Bolger, Lisa Jo Paschal-Alcorn, Mark Stephen Katz, Michael D Ohalleran, Michael Thomas Vanacker, Nicholas Dominic Cortezi, Patrick G Ryan and Timothy William Turner.
View institutional ownership trends
.

How do I buy shares of Ryan Specialty?

Shares of RYAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:RYAN) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -